Chimin Health Management (603222.SH) announced on **** that the company did not implement repurchase in May 2024. As of May 31, 2024, the company had repurchased a total of 10,389,700 shares through centralized bidding trading, accounting for 1.934% of the company's total share capital. The highest purchase price was 9.98 yuan/share, the lowest was 5.00 yuan/share, and the total amount paid was 81,724,613.18 yuan (excluding transaction costs).
济民医疗(603222.SH)：5月公司未实施回购
Chimin Health Management (603222.SH): No repurchase was implemented by the company in May.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.